Buermans, Noortje J. M. L.
van den Bosch, Sharon J. G.
Huffnagel, Irene C.
Steenweg, Marjan E.
Engelen, Marc
Oostrom, Kim J.
Geurtsen, Gert J.
Article History
Received: 6 August 2018
Accepted: 20 August 2019
First Online: 14 September 2019
Ethics approval and consent to participate
: The study protocol was approved by the local Institutional Review Board (METC 2016_012). Written informed consent was obtained from all participants and is available upon request.
: Not applicable.
: N.B., S.B., M.S., K.O. and G.J. report no disclosures.I.H. is consultant to Vertex. M.E. received research grants from Vertex and Minoryx Therapeutics and is consultant to Vertex and Minoryx Therapeutics. None of the disclosures are relevant to the design of this study, nor the manuscript preparation or content.